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Abstract
Nell2 is a neuron-specific protein containing six epidermal growth factor-like domains. We have identified Nell2 as a retinal
ganglion cell (RGC)-expressed gene by comparing mRNA profiles of control and RGC-deficient rat retinas. The aim of this
study was to analyze Nell2 expression in wild-type and optic nerve axotomized retinas and evaluate its potential role in
RGCs. Nell2-positive in situ and immunohistochemical signals were localized to irregularly shaped cells in the ganglion cell
layer (GCL) and colocalized with retrogradely-labeled RGCs. No Nell2-positive cells were detected in 2 weeks optic nerve
transected (ONT) retinas characterized with approximately 90% RGC loss. RT-PCR analysis showed a dramatic decrease in the
Nell2 mRNA level after ONT compared to the controls. Immunoblot analysis of the Nell2 expression in the retina revealed
the presence of two proteins with approximate MW of 140 and 90 kDa representing glycosylated and non-glycosylated
Nell2, respectively. Both products were almost undetectable in retinal protein extracts two weeks after ONT. Proteome
analysis of Nell2-interacting proteins carried out with MALDI-TOF MS (MS) identified microtubule-actin crosslinking factor 1
(Macf1), known to be critical in CNS development. Strong Macf1 expression was observed in the inner plexiform layer and
GCL where it was colocalizied with Thy-1 staining. Since Nell2 has been reported to increase neuronal survival of the
hippocampus and cerebral cortex, we evaluated the effect of Nell2 overexpression on RGC survival. RGCs in the nasal retina
were consistently more efficiently transfected than in other areas (49% vs. 13%; n = 5, p,0.05). In non-transfected or pEGFP-
transfected ONT retinas, the loss of RGCs was approximately 90% compared to the untreated control. In the nasal region,
Nell2 transfection led to the preservation of approximately 58% more cells damaged by axotomy compared to non-
transfected (n = 5, p,0.01) or pEGFP-transfected controls (n = 5, p,0.01).
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Introduction
Nell2 is a thrombospondin-1 (Tsp-1)-like glycoprotein contain-
ing six epidermal growth factor (EGF)-like and several von
Willebrand factor C domains. The nel gene was originally isolated
from a chick embryo-derived cDNA library [1]. It was
ubiquitously expressed during development, but after hatching,
the nel expression was restricted to neural tissues. In developing
chicken retinotectal system, the expression of nel was localized in
specific laminae of the tectum that retinal axons normally do not
enter, suggesting that nel acts as an inhibitory guidance cue for
retinal axons [2]. Two nel-like genes, Nell1 and Nell2, were isolated
from a human and rat brain cDNA library [3], [4]. The Nell2 gene
is more closely related to the nel gene than Nell1 and is expressed
predominantly in the brain with the highest level in the
hippocampus [3]. Similar to Tsp-1-induced signal transduction,
Nell2 signaling has been shown to be mediated by extracellular
signal-regulated kinase (Erk) and c-Jun N-terminal kinase (Jnk).
Through the activation and suppression of Jnk and Erk,
respectively, Nell2 has been reported to support the survival of
neurons from the hippocampus and cerebral cortex [5].
Furthermore, since Erk and Jnk are implicated in the induction
and inhibition of hippocampal long-term potentiation (LTP), it
was suggested that Nell2 may play a role in this process [6], [7].
Evaluation of Nell2-deficient mice showed that this gene is an
essential negative regulator of the neuronal activity important for
LTP induction in the hippocampus [8].
We identified Nell2 as one of the genes, expression of which in
the retina is restricted to retinal ganglion cell (RGC) during our
recent analysis of RGC transcriptome [9]. RGCs provide the final
neuronal output of the retina. They collect visual signals from
bipolar and amacrine cells and transmit this information to the
brain. Based on their morphological characteristics, such as soma
size, dendritic field size, and dendritic ramification, at least 18
different types of RGCs have been identified in the human retina.
Physiologically, these cells can be divided into several major types:
1) motion-sensitive parasol or magnocellular (M) RGCs; 2) color-
sensitive midget or parvocellular (P) RGCs that are responsible for
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central visual acuity; 3) color opponent blue-yellow bistratified
RGCs; 4) RGCs responsible for pupillary reaction; and 5)
melanopsin-containing photosensitive RGCs responsible for the
regulation of circadian rhythm [10], [11], [12], [13], [14], [15].
Degeneration of RGCs and their axons in the optic nerve leads to
vision loss in various optic neuropathies including its most
common form, glaucoma, which affects more than 70 million
people worldwide and if left untreated, can lead to severe visual
impairment and blindness (10% of total blindness cases in the
U.S.)
Understanding the function of Nell2 in RGCs is of particular
interest to us since it has been implicated in promoting survival,
proliferation and differentiation of neuronal cells [5], [16], [17],
[18]. As the pathophysiological mechanisms leading to RGC
degeneration in glaucoma are not well understood and the current
therapies are limited to the reduction of intraocular pressure,
modulation of Nell2 expression could have a potential neuropro-
tective effect to stimulate RGC survival in this disease. In the
present study we characterized Nell2 expression at the mRNA and
protein level in control and optic nerve axotomized retinas,
identified Nell2-interacting proteins in the retina and evaluated its
cell protective role in ONT-induced RGC degeneration.
Results
Nell2 mRNA localization in the retina
In situ hybridization (ISH) was the first experiment to confirm
the results of the microarray data indicating that Nell2 is expressed
in the retina predominantly or exclusively by RGCs. Using Nell2-
specific antisense riboprobes, the expression of this gene in the
adult rat retina was localized to the cells in the GCL (Fig. 1A). No
Nell2 positive staining was detected in any other retinal layer. Nell2
spatial expression was also analyzed in the retinas after ONT,
which leads to rapid and specific degeneration of RGCs. The
estimated number of surviving RGCs in the axotomy model used
in this study was approximately 5–10%, which is consistent with
the results of other studies showing up to 100% of RGC loss by
two weeks after ONT [19]. In retinal sections analyzed by ISH
two weeks after ONT, no Nell2 positive cells were detected. These
results suggest that Nell2-positive cells in the GCL are RGCs.
However, the GCL in the rodent retina contains both RGCs and
non-RGCs, mostly displaced amacrine cells, in an approximately
similar ratio. Therefore, to identity Nell2 positive cells, ISH was
performed on retinas with retrogradely-labeled RGCs. Results
presented in Fig. 1B show that Nell2-positive signals were
colocalized with the Fluorogold (FG) retrogradely-labeled irregu-
larly shaped large and medium size RGCs. Furthermore,
consistent with RGC distribution in the rodent retina, Nell2-
positive cells were present more densely in the posterior region
compared to the peripheral retina. No positive reaction was
present in the retinas subjected to ISH with the sense riboprobe
used in these experiments as a negative control.
Immunohistochemical localization of Nell2 protein in the
retina
To determine Nell2 spatial expression immunohistochemistry
(IHC) was performed on untreated and axotomized rat retinal
sections. The distribution of Nell2 protein in the retina was similar
to its mRNA expression. The most abundant expression of these
proteins was observed in the GCL (Fig. 2 A). Furthermore, all
Nell2-expressing cells in the GCL were colocalized with
retrogradely-labeled RGCs. Analysis of Nell2 protein expression
2 weeks after ONT showed no Nell2-positive cells in the retina
(Fig. 2B). Very few small ramifying FG-stained microglial cell were
present, however these cells were negative for Nell2 expression.
A number of studies analyzing the Nell2 expression pattern
have strongly suggested that this is a secreted glycoprotein that
functions as a trophic factor as well as a signaling molecule during
cell growth and differentiation [5], [18]. Later, a non-secreted
isoform of Nell2 was found to be present throughout the cytoplasm
and was suggested to be involved in intracellular signal pathways
as an interacting partner of PKCb1 [20]. Non-secreted Nell2 is
generated by alternative splicing and lacks the third exon
containing the terminal portion of the secretion signal peptide.
The granular appearance of Nell2 immunohistochemical staining
in RGCs (Fig. 2A) suggests its predominant localization in the
intracellular compartments. This is in agreement with earlier
observations of subcellular localization of Nell2 to the organelles
associated with secretory processes, such as the Golgi apparatus
and endoplasmatic reticulum. To identify Nell2 splicing isoforms
expressed in the retina, an RT-PCR with primers flanking exon 3
was performed (Fig. 3A). In this experiment, the expected length of
RT-PCR products are 308 bp and 179 bp that correspond to
secreted and non-secreted variants of Nell2, respectively (Fig. 3B).
Only one product of approximately 300 bp was detected,
indicating the expression of secreted Nell2 isoform in the retina.
RT-PCR and immunoblot (IB) analyses of Nell2 expression
in the retina
RT-PCR of Nell2 showed a dramatic decrease in the level of
Nell2 mRNA expression 2 weeks after ONT (Fig. 4A). This
observation is in agreement with ISH data indicating a loss of
Nell2-positive cells after axotomy. A western blot analysis of Nell2
protein in untreated retinas revealed the presence of two products
with approximate molecular weight (MW) of 90 kDa and 140 kDa
Figure 1. Nell2 mRNA expression in control and ONT retinas. A
and C. Nell2 mRNA expression was localized to the cells in the GCL. D.
No Nell2 positive cells were detected in retinal sections two weeks after
ONT that leads to RGC degeneration. A and B. All Nell2 in situ
hybridization signals were colocalized with RGCs retrogradely labeled
with FG.
doi:10.1371/journal.pone.0034810.g001
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(Fig. 4B). A similar pattern was observed in a sample containing
protein extract from cortex used in this experiment as a positive
control. The intensity of the band corresponding to 90 kDa
product was approximately 2 fold higher compared to 140 kDa
product. Since the deduced MW of Nell2 is 91,402 Da, it is
suggested that the ,90 kDa and 140 kDa bands represent non-
glycosylated and glycosylated Nell2, respectively. In retinas
subjected to ONT, no 140 kDa product was present, whereas a
very faint 90 kDa band was hardly detectable. This dramatic
decrease in Nell2 protein level correlates with immunohistochem-
ical and in situ data indicating the loss of Nell2-positive cells due to
ONT-induced degeneration of RGCs.
Nell2 interacts with microtubule-actin crosslinking factor
1 (Macf1) in RGCs
To gain insights into potential function of Nell2 in RGCs, Nell2
interacting proteins in the retina were identified with matrix-
assisted laser desorption/ionisation-time of flight mass spectrom-
etry (MALDI-TOF MS). A predominant high MW protein pulled
down by the Nell2 antibody was detected in three consecutive
experiments by coomassie blue staining. This anti-Nell2-immuno-
precipitated product was subjected to MS analysis. Peptide mass
fingerprinting and Mascot analysis of the amino acid sequence
obtained from MALDI-TOF-TOF and MS-MS led to identifica-
tion of this protein as Macf1 (product accession number gi
119627687 and MW ,620 kDa). To further confirm the result
obtained with MS, a reverse immunoprecipitation (IP) with an
Macf1 antibody was performed. Two bands with MW of
approximately 90 and 140 kDa were detected by IB with Nell2
antibody following IP with anti-Macf1 (Fig. 5A). IB with Macf1
antibody of the lysate immunoprecipitated with Nell2 antibody
showed a single high MW band corresponding to Macf1 (Fig. 5A).
The expression pattern of Macf1 in the retina was determined by
immunohistochemistry. Strong Macf1 expression in the GCL and
inner plexiform layer (IPL) was observed (Fig. 5B). Macf1
expression in RGCs was demonstrated by colocalization of Macf1
positive cells with Thy-1 staining, a commonly used marker for
RGCs. The results of MALDI-TOF MS that were further
corroborated with IP/IB and immunohistochemistry data provide
strong evidence for the Nell2 interaction with Macf1 in RGCs.
Overexpression of Nell2 in the retina and RGC survival
The notion that Nell2 could support the survival of injured
RGCs was based on an earlier study [5] demonstrating a cell
protective role of Nell2 in primary neuron cultures of the
hippocampus and cerebral cortex. Nell2 fused to an EGFP
expression construct was used to evaluate the in vivo effect of this
protein on the survival of axotomized RGCs in an ONT rat
model. Constructs were delivered to the retina by electroporation
(ELP). First, we determined the efficiency of ELP-mediated RGC
transfection by comparing the number of EGFP-positive cells
colocalized with FG-labeled RGCs and the total number of FG-
labeled RGCs (Fig. 6A). RGCs in the upper nasal retina were
consistently more efficiently transfected than in other areas.
Figure 2. Immunohistochemical localization of Nell2 in control
and ONT retinas. A and B. Co-localization of Nell2 expression with FG-
labeled RGCs. The distribution of Nell2 protein in the retina was similar
to its mRNA expression. The most abundant expression of these
proteins was observed in the GCL. Furthermore, all Nell2-expressing
cells in the GCL were colocalized with retrogradely-labeled RGCs. C and
D. Loss of Nell2 immunohistochemical staining correlates with the loss
of RGCs 2 weeks after ONT. Analysis of Nell2 protein expression 2 weeks
after ONT showed no Nell2-positive cells in the retina. Very few FG-
positive microglial cells are present.
doi:10.1371/journal.pone.0034810.g002
Figure 3. Expression of Nell2 splicing variants in the retina. A.
RT-PCR analysis was performed to identify Nell2 isoforms. Only one
,300 bp product corresponding to secreted Nell 2 isoform was
detected (lane 1). Lane 2 is a 100 bp DNA ladder. B. Locations of the
primers in the gene used for the PCR are indicated by arrows. The
expected sizes of the products corresponding to secreted and non-
secreted Nell2 isoforms are 308 bp and 179 bp, respectively.
doi:10.1371/journal.pone.0034810.g003
Figure 4. RT-PCR and immunoblot analyses of Nell2 expression
in control and ONT retinas. A dramatic decrease in Nell2 mRNA (A)
and protein (B) levels associated with the loss of RGCs was observed. B.
Nell2 is represented in the retinal extract by 90 kDa and 140 kDa
proteins, which are proposed to be non-glycosylated and glycosylated
Nell2, respectively. Lanes: 1 – control retina; 2 – ONT retina; 3 – cortex.
doi:10.1371/journal.pone.0034810.g004
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Approximately 49% of RGC in the upper nasal area were
transfected, whereas the transfection efficiency for the entire retina
was only ,13% (n= 5, p,0.05; Fig. 6B).
To evaluate the cell protective effect of Nell2 overexpression,
the transfection was performed one day before ONT and RGCs
were counted 2 weeks after ONT. Non-transfected pEGFP-
transfected ONT retinas were used as controls. In non-transfected
ONT retinas, the loss of RGCs was approximately 90% (218636
cells/mm2 survived) compared to the untreated retinas (Fig. 7). No
significant difference was observed in ONT-induced RGC loss in
pEGFP-transfected versus non-transfected eyes. This was true for
both the entire retina and the upper nasal region. The numbers of
survived RGCs in pNell2-EGFP transfected retinas were approx-
imately 265638 and 344631 per mm2 in the whole retina and
upper nasal region, respectively (Fig. 6). Virtually all of the
surviving RGCs in the nasal region were pNell2-EGFP-transfect-
ed. These results indicate that relatively efficient transfection of
RGCs with a Nell2 expression construct (,49% in this
experiment) led to the preservation of approximately 58% more
cells damaged by axotomy compared to the non-transfected (n= 5,
p,0.01) or pEGFP-transfected controls (n = 5, p,0.01).
Discussion
Nell2 has been identified as a gene, the expression of which in
the retina is restricted or predominant in RGCs [9]. The present
study was initiated with the aim to characterize Nell2 expression in
the retina and evaluate its potential neuroprotective function. To
our knowledge, this is the first study describing expression and
potential role of Nell2 in the retina. Expression of this gene was
analyzed at both mRNA and protein levels in wild type retinas and
in retinas of the ONT model of RGC degeneration. ISH and
immunohistochemistry were performed to determine the spatial
expression of Nell2 in the retina. Nell2 mRNA was specifically
localized to retrogradely-labeled RGCs confirming the results of
the microarray analysis. Furthermore, both RT-PCR and ISH on
retinal sections from ONT animals, in which ,90% of RGCs
degenerate by two weeks after the injury showed near complete
Figure 5. A reverse immunoprecipitation with a MACF1 antibody followed by immunoblot analysis with Nell2 antibodies and
spatial expression of Macf1 in the retina. A. Two products with MW of approximately 90 and 140 kDa were detected by IB with Nell2 antibody
following IP with anti Macf1. IB with MACF1 antibody of the lysate immunoprecipitated with Nell2 antibody showed a single high MW band
corresponding to Macf1. B. Macf1 immunohistochemistry in retinal sections showed predominant Macf1 expression in the GCL and inner plexiform
layerI (IPL). Expression of Macf1 in RGCs and their dendrites was shown by colocalization of Macf1 positive signals with Thy-1 staining, a commonly
used marker for RGCs.
doi:10.1371/journal.pone.0034810.g005
Figure 6. Electroporation-mediated in vivo transfection of RGCs with Nell2 expression construct. A. Co-localization of pNell2-EGFP-
transfected cells with FG-labeled RGCs. A few EGFP-positive cells were present in temporal retinas. Most transfected cells were in the nasal retina.
Most transfected cells in the retina were colocalized with RGCs. No EGFP staining was observed in non-transfected retinas. B. Quantitative analysis of
ELP-mediated transfection efficiency. Approximately 49% of RGCs in the upper nasal region of the retina were transfected with pNell2-EGFP, whereas
the average number of transfected RGCs across the entire retina was approximately 13% (n= 5). *p,0.05.
doi:10.1371/journal.pone.0034810.g006
Nell2 Supports Survival of Retinal Ganglion Cells
PLoS ONE | www.plosone.org 4 April 2012 | Volume 7 | Issue 4 | e34810
loss of Nell2 mRNA expression. In agreement with the mRNA
data, Nell2 protein expression was also localized to RGCs. A
granular appearance of Nell2 immunoreactivity in RGC somas
suggests an enriched localization of this protein in the intracellular
compartments. This observation is in agreement with earlier
reports on preferential localization of Nell2 at distinct subcellular
structures, presumably at the endoplasmic reticulum, Golgi
apparatus and vesicles [20]. Although, as noted above, both,
secreted and cytosolic splicing isoforms have been identified for the
Nell2 [20], results of RT-PCR demonstrate that Nell2 in the retina
is represented only by one splicing variant corresponding to the
secreted form. EGF-like domain-containing proteins are mostly
extracellular [21], but some are intracellular; for instance
amphiregulin is localized to the nucleus [22] and prostaglandin
endoperoxide H synthases to the endoplasmic reticulum and
nuclear envelopes [23].
Nell2 is represented in the retinal extract by 90 kDa and
140 kDa proteins, which are proposed to be non-glycosylated and
glycosylated Nell2, respectively. Both products were also present in
cortex extract that was used in this experiment as a positive
control. This data is in full agreement with an earlier report
analyzing expression of Nell2 in various neuronal tissues including
the olfactory bulb, hippocampus, cerebral cortex, thalamus,
hypothalamus, cerebellum, and medulla [24]. The distribution
of these proteins in the retina was similar to that observed in the
olfactory bulb, hippocampus and cerebral cortex, where a 90 kDa
product was more abundant than 140 kDa. The opposite pattern
was present in the hypothalamus. Interestingly, the recombinant
Nell2 expressed in cultured cells exist only as a 140 kDa
glycosylated protein. Digestion with N-glyconase converts the
140 kDa product into 90 kDa protein [4]. With respect to the
cellular specificity of Nell2 expression in the retina, the fact that in
RGC-deficient (due to optic nerve axotomy) retinas the immuno-
reactive products corresponding to Nell2 were hardly detectable
provides additional evidence that this protein is expressed in
RGCs.
The dominant expression in early post-natal stages, as
compared to the adult stage, suggests the role of Nell2 in neuron
differentiation, including neurite extension and synapse formation
[8], [24]. In the adult rat brain Nell2 expression was restricted to
neurons and was not detected in glial cells and white matter,
suggesting that Nell2 may also play an important role in
differentiated neurons. Since the mechanism of function of Nell2
is unknown, we performed MS analysis to identify proteins
interacting with Nell2. One protein, Macf1, was consistently
present in IP reactions carried out with Nell2 antibodies and
retinal lysate. Macf1 is a highly conserved ubiquitously expressed
cytoskeletal linker protein containing N-terminal actin-binding
domains, followed by plakin domains, extended spectrin repeat
domains, EF-hand motifs, and C-terminal microtubule-binding
domains [25]. High levels of Macf1 were detected in neuronal
tissues [26]. Mice with standard MACF1 knockout (KO) are
embryonic lethal by E10, whereas conditional KO animals die
within 24–36 h after birth [27]. Multiple developmental brain
defects, including a disorganization of the cerebral cortex,
heterotopia of the hippocampal pyramidal layer, aplasia of the
corpus callosum and anterior and hippocampal commissures,
altered shapes of the lateral ventricles, and hypotrophy and
disorganization of thalamocortical fibersin, were observed in mice
with a conditional Macf1 KO [27]. The observed developmental
defects were related to positive regulation of the Wnt signaling
pathway: Macf1 associated with the core canonical Wnt protein
complex containing Axin, Apc, Gsk3b, and b-catenin, and may be
involved in the translocation of the proteins of the Axin complex
Figure 7. The neuroprotective effect of Nell2 expression on axotomized RGCs. The cell protective effect of Nell2 was correlated with the
transfection efficiency. Nell2-mediated cell protective effect for the entire retina (approximately 13% of transfected RGCs) was calculated to be only
about 10%. In the nasal region of the retina with highest numbers of transfected RGCs (,49%), the Nell2 overexpession supported survival of
approximately 58% more RGCs than in non-transfected (n = 5) or pEGFP-transfected (n = 5) control retinas. *p,0.01.
doi:10.1371/journal.pone.0034810.g007
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from the cytoplasm to the plasma membrane [28]. Although not
confirmed by experimental data, we can hypothesize that Macf1
assists Nell2 translocation to synaptic terminals and its possible
function in axonal transport, release and the recycling of synaptic
vesicles [29].
In addition to differentiation and proliferation of neuronal cells,
Nell2 has been reported to promote cell survival [5], [16], [17],
[18]. Aihara et al. reported that Nell2 promotes survival of
primary cultured hippocampal and cortical neurons [5]. They
found that treatment with Nell2 increased JNK phosphorylation
and decreased phosphorylation of Erk, suggesting that Nell2-
induced neuronal survival is partly due to modulation of mitogen-
activated protein kinase (Mapk) activities. Nell2 has also been
shown to be involved in promoting the neuronal survival required
for the formation of a sexually dimorphic nucleus of the preoptic
area in male rats [16]. Estrogen-induced survival of neuropro-
genitor HiB5 cells may be mediated in part by trans-activation of
Nell2 [17]. The blockade of Nell2 endogenous synthesis in HiB5
cells resulted in a decrease in Erk1/2 phosphorylation and in a loss
of the cell survival effect. These data suggest that the Nell2
transcriptional activation by estrogen contributes to estrogen-
mediating cell survival via the Erk signaling pathway.
Identification of new factors for RGC neuroprotection is of
fundamental importance, since the degeneration of these cells and
their axons in the optic nerve is the cause of vision loss in various
optic neuropathies including glaucoma [30], [31], [32]. Since the
exact molecular pathways of RGC death in glaucomatous
neurodegeneration are not well understood, several avenues of
RGC neuroprotection are being investigated, including blocking
glutamate excitotoxicity, stabilizing Ca2+ homeostasis, inhibiting
nitric oxide production, supplying neurotrophins, enhancing the
stress protein response, preventing apoptosis, improving blood
flow to the optic nerve, and modulating immunologic status by
vaccination [33], [34], [35], [36], [37], [38], [39]. Earlier, we have
analyzed changes in gene expression associated with glaucomatous
retinas in a rat model of a disease (unpublished data). Based on
these data, we evaluated the role of several genes, including
crystallins alphaA and alphaB and thiredoxins 1 and 2, the
alterations in expression of which could affect RGC survival [40],
[41], [42]. In this study, we tested our hypothesis that Nell2 may
support RGC survival. The hypothesis was based on our findings
indicating that Nell2 expression in the retina is restricted to RGCs
and on earlier observations demonstrating a Nell2-mediated cell-
protective effect. We used the rat optic nerve axotomy model,
since it is characterized by highly reproducible, rapid and specific
degeneration of RGCs. Our data indicate that Nell2 overexpres-
sion supports the survival of RGCs after axotomy. The cell-
protective effect was more evident in the upper nasal retina where
the ELP-mediated RGC transfection efficiency was approximately
49%. In this region, Nell2 transfection increase the number of
survived RGCs by approximately 58% compared to non-
transfected or EGFP-transfected contralateral axotomized retinas.
We believe that the neuroprotective effect of Nell2 observed in this
study could be even higher if the RGC transfection across the
retina was more efficient. This pattern of regional ELP-mediated
transfection was also observed earlier in our study on the role of
thioredoxins in survival of RGCs. An important advantage of
relatively efficient focal transfection and subsequent cell protection
in the transfected region is that the other parts of the retina can
serve as internal controls eliminating concerns related to possible
variations in RGC density between animals and between two eyes
of the same animal.
In summary, in the present study, we have demonstrated that
Nell2 expression at both mRNA and protein levels is localized to
RGCs in the retina. It is expressed as a cytosolic protein with a
MW of approximately 140 kDa and 90 kDa corresponding to
glycosylated and non-glycosylated proteins, respectively. The
expression of Nell2 mRNA and protein in RGC-deficient retinas
2 weeks after optic nerve axotomy was dramatically decreased to
almost non-existent levels, supporting the Nell2 mRNA and
protein cellular localization data. The neuroprotective effect of
Nell2 was clearly demonstrated in axotomized retinas, in which
the overexpression of this gene in approximately 49% of
transfected RGCs resulted in almost 58% increase in RGC
survival compared to non-transfected or pEGFP-transfected
controls.
Materials and Methods
ONT model
The use of animals for this study was approved by the Animal
Research Committee of the University of California, Los Angeles
and was performed in compliance with the Association for
Research in Vision and Ophthalmology Statement for the Use
of Animals in Ophthalmic and Vision Research. This study was
specifically approved by the University of California, Los Angeles
Animal Research Committee.
To generate the optic nerve transection (ONT) model, the
animals (adult male Wistar rats weighing 250–300 g) were
anesthetized by inhalation of an isofluroane (1.5–3.5%) in oxygen,
the optic nerve was exposed through a lateral conjunctival
incision, and the optic nerve sheath was incised 2 mm longitudi-
nally, starting 3 mm behind the eye. A cross section of the optic
nerve was made through the opening of the optic nerve sheath,
with care not to damage the adjacent blood supply. The
conjunctival incision was sutured and Tobrex ophthalmic
ointment (tobramycin; Alcon, Fort Worth, TX) was applied
topically. The ONT procedure was performed on one eye of each
rat. Animals were euthanized two weeks after the procedure and
eyeballs were enucleated and bisected. Retinas were dissected from
the eyeballs for counting cells in the GCL, RNA isolation, ISH,
immunoblot and IHC.
RGC counting
RGCs were retrogradely labeled by placing a piece of Gelfoam
soaked with 6% FG (Fluorochrome, Denver, CO) to the proximal
cut surface of the optic nerve at the time of optic nerve axotomy.
One day later, the eyes were enucleated and immersed in 4%
paraformaldehyde in a 0.1 M phosphate buffer for 1 hour, the
retinas were dissected, mounted on glass slides and divided into
superotemporal, inferotemporal, superonasal, and inferonasal
quadrant. Three sampling fields (0.32 mm60.24 mm) were
collected at each region 1, 2, and 3 mm from the center of the
optic nerve in each retinal quadrant under fluorescent microscopy
(LSM410, Carl Zeiss, Oberkochen, Germany) at 2006magnifi-
cation. The numbers of RGCs in thirty-six sampling fields from
each retina were counted and averaged. Morphologically
distinguishable glial cells (bright and small cells) were not counted.
Quantification of RGCs was carried out in a masked manner.
In situ hybridization
The total retinal RNA and sequence-specific primers 59-
ACAGTTGACCTCTCCTGCTG (forward) and 59-TCATTC-
CACGGCTTCAGTGAG (reverse) were used in RT-PCR to
obtain a Nell2 DNA fragment. DNA fragment was subcloned into
pCRII-Topo vector (Invitrogen, Carlsbad, CA), which contains
sequences for Sp6 and T7 promoters. Template DNA was
prepared by linearizing the plasmid DNA with the Bam HI or
Nell2 Supports Survival of Retinal Ganglion Cells
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Xho I restriction enzymes. Digoxigenin (DIG)-labeled antisense
and sense cRNA probes were synthesized by in vitro transcription
with either T7 or Sp6 RNA polymerase according to the
manufacturer’s protocol (Roche Applied Science, Indianapolis,
IN). Sense RNA probes were used in these experiments as the
negative control.
ISHs were performed according to the standard protocol with
some modifications. Briefly, 10 um-thick frozen sections fixed in
4% paraformaldehyde/phosphate-buffered saline (PBS) were
washed with PBS for 30 min, and equilibrated for 15 min in 56
SSC (0.75 M NaCl, 0.075 M Na-Citrate). Prehybridization was
carried out for 2 h in a solution containing 50% formamide, 56
SSC and 40 ug/ml salmon sperm DNA. Sections were then
hybridized for 12–24 h in a humid chamber at 60uC in a
prehybridization solution, with the addition of the DIG-labeled
Nell2 cRNA probes at a concentration of 400 ng/ml. Following
hybridization, slides were washed twice with 26 SSC and twice
with 0.16 SSC at 65uC for 1 h. Immunological detection was
performed with alkaline phosphatase (AP) conjugated anti-DIG
antibodies at 4uC for 12–14 h. Following incubation with the
DIG-AP antibody, color staining was developed by incubation
sections with NBT/BCIP (Roche Applied Science).
mRNA analysis
The total retinal RNA was extracted with RNAzol B (Tel-Test,
Friendswood, TX), DNase treated with Turbo DNA-free (Am-
bion, Austin, TX) and purified with RNeasy MiniElute Cleanup
kit (Qiagen, Valencia, CA). The 1st strand cDNA from 5
micrograms of the total RNA was reverse transcribed with oligo-
dT primer and M-MuLV (NEB, Beverly, MA). The cDNA was
amplified by PCR with primers specific to the target sequence at
the following conditions: 3 min at 95uC; 25 cycles of denaturing
(95uC for 30 s), annealing (60uC for 15 s), and extension (72uC for
30 s); and a final extension of 7 min at 72uC. First strand cDNA
dilutions in the PCR were adjusted to be within the linear range of
amplification. To confirm that equivalent amounts of 1st strand
were included in the assay, b-actin was used as a standard. The
following primers were used in semi-qPCR: for Nell2, 59-
ACAGTTGACCTCTCCTGCTG (forward) and 59-TCATTC-
CACGGCTTCAGTGAG (reverse); and for b-actin, 59-CTA-
GACTTCGAGCAAGAGATGGCCACT (forward) and 59-
TAGGAGCCAGGGCAGTAATCTCCTTCT (reverse).
To identify Nell2 splicing variants, 1st strand retinal cDNA was
used as a template in a PCR with 59-ACTGAGACGATG-
CACGCCATG (forward) and 59-TGGATCTGTTTCAGGGT-
CACC (reverse) Nell2-specific primers. PCR conditions following:
3 min at 95uC; 30 cycles of denaturing (95uC for 30 s), annealing
(55uC for 30 s), and extension (72uC for 45 s); and a final
extension of 10 min at 72uC.
Immunoblot analysis
Aliquots of 2–10 ug of detergent-soluble retinal protein were
separated on a 12% SDS-polyacrylamide gel and transferred to
the membrane (Immobilon-P; Millipore, Billerica, MA). After
incubation with primary antibodies to Nell2 (1:200; Sigma, St
Louis, MO or 1:2000; Santa Cruz Biotechnology, Santa Cruz,
CA,) or MACF1 (1:2000, Santa Cruz Bioteachnology), the
membranes were treated with peroxidase-conjugated secondary
antibodies (Santa Cruz Biotechnology) for 1 hour and the
immunoreactive bands were detected by chemiluminescence with
ECL Western Blotting Detection Reagents (GE Healthcare
Biosciences, Piscataway, NJ). To confirm equal protein loading
of retinal lysates from different animals, membranes were
reprobed with a monoclonal antibody to a housekeeping gene,
GAPDH (1:10000; Sigma).
Immunohistochemistry
Five rats were used for IHC. Ten-micrometer thick retinal
sections were incubated with primary mouse monoclonal anti-
Nell2 antibody (provided by Dr. N. Saito) diluted 1:500 overnight
at 4uC. Sections were washed with 0.01 M PBS/0.2% Triton X-
100 for 30 min and incubated with fluorescent Alexa Fluor 568
dye labeled goat anti-mouse IgG (Molecular Probes, Eugene, OR)
diluted 1:2000 for 1 hour at room temperature. Sections were
mounted and the digital images were captured. The specificity of
the immunoreaction was controlled by the exclusion of the
primary antibody.
Immunoprecipitation
Five rats were used for IP. Rat retinas and cortexes were
homogenized in RIPA buffer (150 mM NaCl, 1% IGEPAL CA-
630, 0.5% sodium deoxycholate, 0.1% SDS, 50 mM Tris, 1 mM
PMSF) and the samples were centrifuged at 120006g for
10 minutes at 4uC. IP was carried out with Immunoprecipitation
Starter Pack (GE Healthcare), according to the manufacturer’s
instructions. Briefly, the supernatants were incubated with
antibodies for Nell2 (Santa Cruz Biotechnology) or MACF1
(Santa Cruz Biotechnology) 1 h at 4uC, followed by incubation
with Protein G Sepharose 4 Fast Flow for another 1 h at 4uC.
After samples were washed three times with ice-cold wash buffer
and the supernatants were removed by centrifugation at 12,0006g
for 1 min, proteins were precipitated. The proteins were then
isolated from the beads using immunoblot loading buffer for 4 min
at 95uC, separated on a 7% SDS-polyacrylamide gel (Bio-Rad,
Hercules, CA) and processed for Coomassie brilliant blue or Silver
staining (Thermo Scientific, Rockford, IL), according to the
manufacturer’s instructions.
Proteome analysis by matrix-assisted laser desorption/
ionisation-time of flight mass spectrometry (MALDI-TOF
MS)
Proteins were in-gel digested using trypsin (Roche Applied
Science) according to manufacturer’s protocol. After digestion, the
gel pieces were extracted with 50% acetonitrile (ACN), 50% 0.1%
formic acid (FA) (v/v) for 15 min. The supernatant was collected
and the gel pieces were covered with 5% FA for 15 min before the
same volume of ACN was added. After incubation for 10 min, the
supernatant was collected. The pooled supernatants were then
dried in a vacuum centrifuge and stored at 220uC. The trypsin-
digested peptides concentrated by Ziptip C18 (Millipore) were
placed on the anchor chip of a MALDI-TOF MS (Ultrafrex,
Bruker Daltonics, Bremen, Germany) together with 100 fmol of a
bradykinin fragment (m/z of 757; Sigma) as an internal control
and 0.3 mg of 4-hydroxy-a-cinnamic acid matrix. Next, mass
spectra of peptide peaks were detected using the automatic linear
positive mode for simple comparison between the sample groups.
The MS analysis was then performed using reflector mode to
obtain accurate masses for the peptides. Finally, the MS/MS
(TOF/TOF) analysis and subsequent sequence searching using
Mascot were performed to identify the sequences of peptides of
interest. A comparative analysis of the mass spectra of the peptide
peaks was performed by using ClinProt Tools software v.1.0
(Bruker Daltonics). The intensities of the detected peptides were
normalized using that of the bradykinin fragment.
Nell2 Supports Survival of Retinal Ganglion Cells
PLoS ONE | www.plosone.org 7 April 2012 | Volume 7 | Issue 4 | e34810
Nell2 expression construct
Enhanced green fluorescent protein (EGFP)-fused Nell2 expres-
sion construct was prepared in a pEGFP-N3 vector (Clontech,
Mountain View, CA). The Nell2 coding region was obtained by
RT-PCR with sequence-specific primers containing Eco RI and
Bam HI restriction sites integrated into the forward (Nell2-1, 59-
CTAGAATTCGAGACGATGGACTGAGACGAT) and reverse
(Nell2-2, 59- ATATGGATCCCAGCTCCTGGAGGCAC) prim-
ers, respectively. First strand retinal cDNA synthesized with oligo-
dT primer as described above was used as a template in PCR. The
PCR product was digested with the Eco RI and Bam HI and
cloned into pEGFP-N3 vector upstream of EGFP open reading
frame.
Electroporation and the efficiency of RGC transfection
pEGFP or pNell2-EGFP expression constructs were delivered to
the retina by ELP as described previously with minor modifica-
tions [43], [44], [45]. Briefly, animals were anesthetized with an
intramuscular injection of 0.8 ml/kg of a cocktail containing 5 ml
ketamine (100 mg/ml), 2.5 ml xylazine (20 mg/ml), 1.0 ml
acepromazine (10 mg/ml), and 1.5 ml normal saline. Twenty ug
(4 ul) of plasmid DNA was injected under stereo-microscopy into
the vitreous cavity 0.5 mm posterior to the limbus. Ten minutes
later, the cathodal electrode was placed on the cornea, and an
18G-needle anodal electrode was inserted subcutaneously at the
middle of the forehead. Two sets of 5 electric pulses with 10 min
interval were generated with ECM 830 Pulse Generator (BTX,
San Diego, CA) and delivered to the animals. Pulse parameters
were as followed: electric field strength of 6 V/cm, pulse duration
of 100 ms, and a stimulation pattern of five pulses at a frequency
of one pulse/second.
The efficiency of RGC transfection was evaluated 7 days after
ELP. RGCs were retrogradely labeled with FG, as described
above, 5 days after ELP. FG and EGFP were visualized under
fluorescence microscopy with a wide-band ultraviolet (UV)
excitation filter (330–390 nm excitation and 420–480 nm emis-
sion) and with a green spectral filter (460–490 nm excitation and
510–550 nm emission), respectively. The efficiency of RGC
transfection was determined by comparing the number of
EGFP-positive cells colocalized with FG-labeled RGCs with the
total number of FG-labeled RGCs at 1, 2 and 3 mm from the
center of the optic nerve in each of the retinal quadrants (see RGC
Counting above).
Statistical Analysis
Data are presented as the mean 6 standard deviation (SD).
Differences among groups were analyzed by one-way ANOVA,
followed by the Scheffe´ or Mann-Whitney test. P,0.05 was
considered statistically significant.
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